skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.6.0

Summary

Query: Party Name contains all words: NOVARTIS AG
Number of results: 326+
Results are in reverse chronological order

Page #13. Previous 1 10 11 12 14 Next
Proceeding
Filing Date
Defendant(s),
Property(ies)
Plaintiff(s),
Property(ies)
86524752
07/14/2015
Portola Pharmaceuticals, Inc.
Mark: XAVERZA S#:86524752
Novartis AG
79158523
06/03/2015
NOVARTIS AG
Mark: REINDOSE S#:79158523
Ares Trading S.A.
MERCK KGAA
86525026
05/12/2015
Merck Sharp & Dohme Corp.
S#:86525026
Novartis AG
SUMITOMO DAINIPPON PHARMA CO., LTD.
86525025
05/06/2015
Merck Sharp & Dohme Corp.
S#:86525025
Novartis AG
SUMITOMO DAINIPPON PHARMA CO., LTD.
79158879
07/15/2015
Novartis AG
Mark: TISTELTO S#:79158879
Boehringer Ingelheim International GmbH
91221703
04/21/2015
Novartis AG
Mark: BRAXMADA S#:79153933
Boehringer-Ingelheim Pharma GmbH & Co. KG
Mark: PRADAXA S#:78282869 R#:2874805
Mark: PRADAXA S#:85133694 R#:3977066
Mark: PRADAXA S#:79064548 R#:3661185
91221675
04/27/2015
Bausch & Lomb Incorporated
Mark: RESTORYL S#:86306959
Novartis AG
Mark: RESTOR S#:78005941 R#:2772538
79158875
07/15/2015
Novartis AG
Mark: STOZILTO S#:79158875
Boehringer Ingelheim International GmbH
79157395
04/06/2015
NOVARTIS AG
Mark: QUVYA S#:79157395
Baxter International Inc.
91221364
04/06/2015
Merck KGAA
Mark: MSDIALOG OPENING A NEW DIALOGUE IN MS S#:85913053
Mark: DIALOGMS OPENING A NEW DIALOGUE IN MS S#:86008704
Mark: MSDIALOG S#:86059970
Novartis AG
Mark: MS DIALOGUES S#:86131663
Mark: MS DIALOGUES S#:86131661
79157839
07/08/2015
Novartis AG
Mark: VYNAMBRI S#:79157839
Merck Sharp & Dohme Corp.
86396645
03/31/2015
Synthon Holding B.V.
Mark: SENSIGO S#:86396645
Novartis AG
86415898
03/23/2015
Elixir Medical Corporation
Mark: NOVOLIMUS S#:86415898
Novartis AG
79156353
06/08/2015
Novartis AG
Mark: ARAQATA S#:79156353
Aratana Therapeutics, Inc.
86376750
03/10/2015
Adjuvants Plus Inc.
Mark: DONGUARD S#:86376750
Novartis Tiergesundheit AG
85937246
03/10/2015
Aclaris Therapeutics, Inc.
Mark: ACLARIS S#:85937246
Novartis AG
91220913
03/04/2015
Novaerus US, Inc
Mark: NOVAERUS S#:86271259
Mark: NOVAERUS S#:86271268
Novartis AG
Mark: NOVARTIS S#:75131409 R#:2336960
Mark: NOVARTIS S#:78365657 R#:2997235
91220546
02/09/2015
Cuprum LXV AG
Mark: RESTOR S#:86207357
Novartis AG
Mark: RESTOR S#:78005941 R#:2772538
Mark: IQ RESTOR S#:85780938 R#:4513350
79153933
01/22/2015
NOVARTIS AG
Mark: BRAXMADA S#:79153933
Boehringer-Ingelheim Pharma GmbH & Co. KG
86059970
01/22/2015
MERCK KGAA
Mark: MSDIALOG S#:86059970
Novartis AG
86365254
01/19/2015
Glaxo Group Limited
Mark: GADEPTA S#:86365254
Novartis AG
91219769
12/15/2014
NXThera, Inc.
Mark: RESTOR S#:86075496
Novartis AG
Mark: RESTOR S#:78005941 R#:2772538
Mark: IQ RESTOR S#:85780938 R#:4513350
86271268
12/04/2014
Novaerus US, Inc
Mark: NOVAERUS S#:86271268
Novartis AG
86271259
12/04/2014
Novaerus US, Inc
Mark: NOVAERUS S#:86271259
Novartis AG
86302909
11/26/2014
L. Perrigo Company
Mark: CLEARCARE S#:86302909
Novartis AG
Page #13. Previous 1 10 11 12 14 Next

Results as of 02/28/2025 12:21 AMSearch again
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY